An observational study in Hematopoietic and Lymphatic System Neoplasm and Malignant Solid Neoplasm, sponsored by Children's Oncology Group. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Children's Oncology Group · Observational
This study is being done to understand how digital strategies (e.g., electronic health record [EHR]-technology, third-party platforms, and institution-developed solutions) can be used to deliver and respond to evidence-based distress screening at Children's Oncology Group (COG) National Cancer Institute Community Oncology Research Program (NCORP)-affiliated practices with the long-term goal of improving the quality of care and equitable patient access to psychosocial supports.
PRIMARY OBJECTIVES:
I. To characterize the institutional context for future implementation of digital distress screening strategies (e.g., electronic health record [EHR]-technology, third-party platforms, and institution-developed solutions).
II. To assess the availability, type, and organizational context of psychosocial staff and services accessible to pediatric patients who screen positive for distress across National Cancer Institute (NCI) Community Oncology Research Program (NCORP) practices serving pediatric patients guided by the Consolidated Framework for Implementation Research (CFIR).
OUTLINE: This is an observational study.
Practices complete the Practice Characteristics and Nomination Form at enrollment. Practice representatives then complete the Practice Respondent Survey and may complete a Practice Respondent Interview on study.
Children's Oncology Group is the lead sponsor of 448 studies on the registry; 36 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 11 (92%) have results posted.
Counted across the registry records on this site, refreshed daily.
Non-patient providers and other professional disciplines working at a COG NCORP-participating practice
Inclusion Criteria:
* Practices must be a COG NCORP-participating practice (i.e., NCORP Site)
Non-Patient Providers and Other Professional Disciplines must be one of the following provider or other professional discipline types:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Practices complete the Practice Characteristics and Nomination Form at enrollment. Practice representatives then complete the Practice Respondent Survey and may complete a Practice Respondent Interview on study.
Other: Non-Interventional Study
Non-interventional study
Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study
CFIR inner setting characteristics
Will assess organizational structural characteristics (physical, IT, and work infrastructure) and available resources (funding, materials, and equipment) that support and deliver distress screening to patients and caregivers as measured by the CFIR Inner Setting measure and semi-structured interview. Descriptive statistics will be used to understand responses across sites. Means and standard deviations, as well as one and two-way tables and figures will be used to summarize and understand survey responses and inter relationships among inner setting, innovation, screening practices, and site characteristics. Survey responses will be described separately for each respondent type to capture the distinct perspectives and experiences of each group. A quasi-deductive approach will be used to analyze the qualitative data, emphasizing first a deductive approach.
Time frame: Up to study completion, up to 1 year
CFIR innovation characteristics
Will assess clinician/staff representative perceptions of the relative advantage, complexity, and compatibility of EHR-integrated distress screening as measured by the CFIR Intervention Characteristics measure and semi-structured interview. Descriptive statistics will be used to understand responses across sites. Means and standard deviations, as well as one and two-way tables and figures will be used to summarize and understand survey responses and inter relationships among inner setting, innovation, screening practices, and site characteristics. Survey responses will be described separately for each respondent type to capture the distinct perspectives and experiences of each group. A quasi-deductive approach will be used to analyze the qualitative data, emphasizing first a deductive approach.
Time frame: Up to study completion, up to 1 year
Informational assessment of current screening practices
Will assess availability of psychosocial services, methods and measures used, screening timing, frequency, and repeat screening practices; workflows for responding to positive screens; referral pathways and follow-up procedures; documentation and tracking of screening, referrals, and follow-up activities within the EHR; and metrics used by sites to define and evaluate successful screening programs.
Time frame: Up to study completion, up to 1 year
No study locations are listed for this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.